Zurn Elkay raises 2025 guidance with 5%+ core sales growth and $420M–$430M EBITDA outlook amid robust Q2 results

Zurn Elkay raises 2025 guidance with 5%+ core sales growth and $420M–$430M EBITDA outlook amid robust Q2 results